BOTOX-New clinical drug trial for Migraine patients

Do you suffer from at least 6 migraine attacks a month? If so, you may be a candidate for a clinical drug trial testing a new form of botulinum toxin. Arizona Neuroscience Research at CNS is participating in this important trial. Drs. Gitt and Zuniga are investigators...

Timing MS Medications with COVID-19 Vaccines

Based on expert consensus and available data, we offer the following guidance regarding COVID-19 vaccination for people on MS disease modifying therapies (DMTs). This guidance will be updated as new data are available.The Pfizer BioNTech, Moderna and Janssen/J&J...